Entospletinib (GS-9973) selectively inhibits SYK and presents a synergistic antitumor effect with vincristine, both in a panel of DLBCL cell lines and in a DLBCL tumor xenograft model [93]. The gene discussed is SYK; the disease is diffuse large B-cell lymphoma.